Answers are grounded in this paper and cite their sources.
The basement membrane (BM) functions crucially in sustaining tissue homeostasis and influencing tumorigenesis and progression, yet its prognostic significance in breast cancer (BRCA) remains unclear. The TCGA-BRCA and GSE20685 datasets were combined with a previously reported set of basement membrane-associated genes (BMGs) for analysis. BMG scores were calculated via single-sample gene set enrichment analysis (ssGSEA), and associated gene modules were classified by weighted gene co-expression network analysis (WGCNA). Key candidate genes were identified through differential analysis. A Riskscore model for BRCA was constructed using univariate Cox regression, LASSO regression, and multivariate Cox regression analyses. The associations of the model with the immune microenvironment of BRCA were evaluated using ssGSEA, ESTIMATE, and MCP-counter, and TIDE algorithms. The one-class logistic regression (OCLR) algorithm was used to calculate the mRNA expression-based stemness index (mRNAsi), and its association with cancer drug sensitivity was subsequently analyzed. In vitro validation was additionally performed using MDA-MB-231 cells. BMGs scores were significantly lower in BRCA tumor samples, and patients with higher BMG scores exhibited a better prognosis. WGCNA identified the black module as significantly associated with BMGs. Genes at the intersection of the WGCNA-derived black module and differentially expressed genes (DEGs) were enriched in pathways including cell adhesion and ECM-receptor interaction. The final 7-gene risk model ( GRIA3 , NACAD , SDC1 , SERPING1 , TMEM92 , WLS , and WNT7B ) reliably distinguished high-risk patients from low-risk patients and was validated in GSE20685 dataset. Immunological analysis revealed that high Riskscore was closely related to lower T-cell infiltration and exhibited features of immune exclusion and immunosuppression. Drug sensitivity analysis indicated that the Riskscore was correlated with DMOG, AP-24,534 and PHA-665,752, and a higher mRNAsi score was observed in high-risk BRCA patients. Additionally, GRIA3 expression was upregulated in MDA-MB-231 cells, while knockdown of GRIA3 expression reduced the proliferation, migration, and invasion of the cells in vitro. The prognostic model constructed based on BMGs may help predict the prognosis of BRCA patients and reflects its association with immune microenvironment characteristics and drug sensitivity. These findings provide a potential reference for risk stratification and future personalized BRCA research, however, further experimental and clinical validation is required. Not applicable.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: